Alcyone Therapeutics Inc., a clinical-stage biotechnology company pioneering next-generation precision genetic therapies and precision delivery solutions of therapies for complex neurological conditions, has officially...
BioVaxys Technology Corp, a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPXâ„¢ platform, has officially signed a Letter...
The Lung Cancer Research Foundation (LCRF), in collaboration with 23andMe Holding Co. and 20 lung cancer advocacy organizations, has officially announced a study, which...
Invitae, a leading medical genetics company, has officially announced the launch of its Unlock™ Behind the Seizure® program, which is designed to provide you...
The US Food and Drug Administration has officially approved Providence Medical Technology's CORUSâ„¢ Posterior Cervical Stabilization System (PCSS), which is designed to treat up...
Immorna Biotherapeutics, Inc a, clinical stage biotechnology company developing both self-replicating and conventional mRNA-based therapeutics and vaccines, has officially secured FDA's approval for its...
Serac Healthcare Limited, a clinical radiopharmaceutical company developing an innovative molecular imaging agent, has officially secured FDA's Fast Track Designation for its 99mTc-maraciclatide as...
The U.S. Food and Drug Administration (FDA) has officially approved Eli Lily's Kisunla™ therapeutic, which is essentially presented as a treatment for Alzheimer’s in...
TruDiagnostic has officially announced the launch of new validated and system-specific trained clocks that mark an industry-first in regards to epigenetic aging analysis of...
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has officially announced the launch of a brand-new all-encompassing...
Neurolief, a leading developer of innovative brain neuromodulation technologies, has officially announced groundbreaking topline results from its pivotal clinical trial, which studied the efficacy...
OM1, the leader in delivering first-in-class RWE (real-world evidence) technological advancements and AI-powered insights, has officially announced the launch of its brand-new Registries Center...